ArticleDiscover oncology2025

ESM1 suppresses LncRNA GAS5/miR-23a-3p/PTEN axis to promote the cisplatin-chemotherapy resistance of ovarian cancer cells via activating the PI3K/AKT pathway.

Hui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.